Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants

Conditions

• Interstitial Lung Disease

Interventions

• DRUG: Azithromycin 250 mg x3/week (3 tablets/week)
• DRUG: Prednisone 10 mg/day
• DRUG: Hydroxychloroquine 400 mg/day
• DRUG: Active Comparator: Standard of care

Sponsor

Assistance Publique - Hôpitaux de Paris